Reference
Bayer Issues Voluntary Recall Nationwide of VITRAKVI (larotrectinib) Oral Solution 20 mg/mL Due to Presence of Microbial Contamination Internet Document : 21 Nov 2023. Available from: URL: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/bayer-issues-voluntary-recall-nationwide-vitrakvir-larotrectinib-oral-solution-20-mgml-due-presence
Rights and permissions
About this article
Cite this article
Recall of larotrectinib (Vitrakvi) due to microbial contamination. Reactions Weekly 1986, 5 (2023). https://doi.org/10.1007/s40278-023-51310-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-51310-8